HomeGRTX • OTCMKTS
Galera Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.96M | -57.11% |
Net income | -1.59M | 63.66% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.96M | 57.14% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.69M | -50.35% |
Total assets | 7.66M | -61.01% |
Total liabilities | 152.02M | -1.50% |
Total equity | -144.36M | — |
Shares outstanding | 75.46M | — |
Price to book | -0.01 | — |
Return on assets | -55.26% | — |
Return on capital | -69.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.59M | 63.66% |
Cash from operations | -2.24M | 53.29% |
Cash from investing | — | — |
Cash from financing | 635.00K | — |
Net change in cash | -1.60M | 66.54% |
Free cash flow | -1.08M | 66.99% |
Previous close
$0.024
Day range
$0.024 - $0.024
Year range
$0.021 - $0.15
Market cap
1.83M USD
Avg Volume
64.91K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2012
Headquarters
Website
Employees
3
